Report cover image

Peripheral Embolic Protection Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

Publisher GlobalData
Published Aug 26, 2024
Length 63 Pages
SKU # GBDT19176695

Description

Peripheral Embolic Protection Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update


Summary

GlobalData's Medical Devices sector report, “Peripheral Embolic Protection Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Peripheral Embolic Protection Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Peripheral Embolic Protection Devices are used to capture and remove plaque debris that are dislodged during interventional procedures.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Peripheral Embolic Protection Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Peripheral Embolic Protection Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Peripheral Embolic Protection Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

63 Pages
    • Peripheral Embolic Protection Devices Overview
    • Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development
    • Peripheral Embolic Protection Devices - Pipeline Products by Segment
    • Peripheral Embolic Protection Devices - Pipeline Products by Territory
    • Peripheral Embolic Protection Devices - Pipeline Products by Regulatory Path
    • Peripheral Embolic Protection Devices - Pipeline Products by Estimated Approval Date
    • Peripheral Embolic Protection Devices - Ongoing Clinical Trials
    • Peripheral Embolic Protection Devices Companies - Pipeline Products by Stage of Development
    • Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development
    • Abbott Vascular Inc Company Overview
    • AorticLab Sarl Company Overview
    • APT Medical Inc Company Overview
    • Artio Medical Company Overview
    • Avantec Vascular Corp Company Overview
    • Cardio-Flow Ltd. Company Overview
    • Cardiovascular Systems Inc Company Overview
    • Emboline, Inc. Company Overview
    • Ev3 Inc Company Overview
    • Filterlex Medical Ltd Company Overview
    • HeMo Bioengineering Ltd Company Overview
    • Innovative Cardiovascular Solutions, LLC Company Overview
    • Innovia LLC Company Overview
    • InspireMD Inc Company Overview
    • Instylla Inc Company Overview
    • Javelin Medical Ltd Company Overview
    • Keystone Heart Ltd Company Overview
    • Marblehead Medical LLC Company Overview
    • MicroPort CardioFlow Medtech Corp Company Overview
    • MicroPort Scientific Corp Company Overview
    • MIV Therapeutics Inc Company Overview
    • Neurosonix Ltd. Company Overview
    • NewMed Medical Co Ltd Company Overview
    • University of Minnesota Company Overview
    • Jul 30, 2024: Silk Road Medical Celebrates Milestone of 100,000 Transcarotid Artery Revascularization (TCAR) Procedures
    • Jul 02, 2024: Penumbra Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024
    • Jun 13, 2024: Medtronic Confirms Global Layoffs
    • May 14, 2024: Instylla Completes Enrollment of Landmark Hypervascular Tumor Pivotal Study
    • Apr 02, 2024: Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUS
    • Mar 12, 2024: Emboline Announces That the First One Hundred Patients Have Been Treated in the IDE Study of the Emboliner Full-Body Embolic Protection Catheter to Minimize Stroke Risk From TAVR
    • Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference
    • Mar 04, 2024: Rapid Medical Receives DeNovo Clearance for BraidE Embolization Assist Device
    • Feb 28, 2024: Boston Scientific Raises $2.2B to Support Purchase of California Medical Device Company
    • Feb 23, 2024: Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
    • Feb 23, 2024: Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering
    • Feb 12, 2024: InspireMD Appoints Principal Investigators for C-GUARDIANS II Clinical Trial of the SwitchGuard Neuroprotection System
    • Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results
    • Dec 20, 2023: InspireMD Announces Issuance of Key U.S. Patent Covering Its SwitchGuard Neuroprotection System
    • Nov 15, 2023: New Published Study Demonstrates Safety and Feasibility of Filterlex Medical's CAPTIS Device in Providing Embolic Protection During TAVR
    • Oct 18, 2023: Edwards Lifesciences to Host Earnings Conference Call on October 25, 2023
    • Aug 28, 2023: Edwards Lifesciences to Present at the 2023 Wells Fargo Healthcare Conference
    • Methodology
    • About GlobalData
    • Contact Us
    • Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.